Volume 23, 2019 Archive

Six issues from 2019 in one convenient archive.

This archive contains the following articles listed by volume, issue and page number:

Issue/Volume	Title
Issues Included
January/February 2019 Vol. 23 No. 1	Volume 23, Number 1
March/April 2019 Vol. 23 No. 2	Volume 23, Number 2
May/June 2019 Vol. 23 No. 3	Volume 23, Number 3
July/August 2019 Vol. 23 No. 4	Volume 23, Number 4
September/October 2019 Vol. 23 No. 5	Volume 23, Number 5
November/December 2019 Vol. 23 No. 6	Volume 23, Number 6

Volume 23, 2019 Articles

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2019 Pg. 4	PreScription: The Cost of Information Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 6-12	An Outlook on the European and Italian Rules to Guarantee Magistral Formulas Author(s): Selmin Francesca, Casiraghi Antonella, Musazzi Umberto M, Fortini Marco, Minghetti Paola
Jan/Feb 2019 Pg. 14-21	The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2 Author(s): Williams LaVonn A
Jan/Feb 2019 Pg. 23-31	Topical Treatment of Primary Focal Hyperhidrosis, Part 1 Author(s): Zur Eyal
Jan/Feb 2019 Pg. 32-33	U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the Line Author(s): Snow Stephen T, Stannard Robert W, Bellis Jennifer, Moss Carrie A
Jan/Feb 2019 Pg. 35-44	Basics of Compounding: Standardization of Compounded Medications Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 47-49	Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding Author(s): Martin Matt
Jan/Feb 2019 Pg. 50	Calculations Author(s): Stockton Shelly J
Jan/Feb 2019 Pg. 52	Ketoprofen 10% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 53	Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 54	Lidocaine Hydrochloride, Diphenhydramine Hydrochloride, Aluminum Hydroxide–Magnesium Hydrochloride–Simethicone Mouthwashes Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 55	Magnesium Sulfate and Lidocaine Hydrochloride Injection in Prefilled Syringes Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 56	Methimazole 5 mg/0.1 mL in Pluronic Lecithin Organogel Gel, Veterinary Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 57	Minoxidil 1-mg/mL in Ora-Plus and Ora-Sweet SF Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 58	Omeprazole 1 mg/mL and 4 mg/mL in Humco Flavor Sweet Sugar-Free Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 59	Orodispersible Film Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 60	Piperacillin 10 mg/mL in 0.9% Sodium Chloride Bladder Irrigation Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 61	Thiamine Hydrochloride 100 mg/mL in SurSPend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 62-64	Chemical Stability of Progesterone in Compounded Oral Rapid-dissolving Tablets Author(s): Sayre Casey L, Cox Christopher, Velazquez Gabriel, Le Minh Thi, Nguyen Amy Hong, Ramos Marjorie, Burrows Anna, Yellepeddi Venkata Kashyap
Jan/Feb 2019 Pg. 65-69	Transdermal Delivery of Metformin Hydrochloride from a Semisolid Vehicle Author(s): Polonini Hudson, Lopes Cândido Paulo José, Andrade Junquiera Laura, Loures Sharlene, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson
Jan/Feb 2019 Pg. 70-76	Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Miller Valicia, Morris Tommy C, Graves Richard A
Jan/Feb 2019 Pg. 77-81	Ex Vivo Evaluation of Intravaginal Progesterone and Testosterone to Treat the Luteal-phase Deficiency and Vaginal Atrophy Author(s): Laque Larissa C, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson, Polonini Hudson C
Jan/Feb 2019 Pg. 82-87	Stability Assessment of Topical Amitriptyline Extemporaneously Compounded with Lipoderm Base, PLO Gel Mediflo 30, and Emollient Cream Author(s): Shakshuki Ayah, Agu Remigius U
Mar/Apr 2019 Pg. 92	PreScription: Compounding with Cannabidiol Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 94-104	Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Author(s): Zur Eyal
Mar/Apr 2019 Pg. 106-111	Nimodipine Compounded Oral Suspension: A True Documented Medical Need Author(s): McElhiney Linda F
Mar/Apr 2019 Pg. 113-119	Penfluridol, a Unique Psychiatric Medicine for the Treatment of Chronic Schizophrenia Author(s): Zur Eyal
Mar/Apr 2019 Pg. 120-121	Patient Access Is a Patient Safety Issue Author(s): Pore David
Mar/Apr 2019 Pg. 123-130	Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding? Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 135-143	Basics of Compounding: Summary of the Official United States Pharmacopeia Monographs for Compounded Preparations Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 144	Calculations Author(s): Stockton Shelly J, Drinnon Stephen D
Mar/Apr 2019 Pg. 146	Acetaminophen 50% Pluronic Lecithin Organogel Gel Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 147	Amlodipine 1 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 148	Captopril 0.8 mg/mL in SyrSpend SF Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 149	Dexamethasone 2 mg/g Topical Paste, Veterinary Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 150	Ketoprofen 10% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 151	Perphenazine 0.5 mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 152	Rosuvastatin 20-mg/5-mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 153	Tacrolimus 0.5 mg/mL in Oral Mix Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 154-156	Towards the Importance of a Roller Mill in Compounding Practice: An Experimental Approach Author(s): Polonini Hudson, Loures da Silva Sharlene, Batista Patrício Fernando, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson
Mar/Apr 2019 Pg. 157-162	Physicochemical Stability of Compounded Naltrexone Hydrochloride Solutions in PCCA Base SuspendIt Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Morris Tommy C, Graves Richard A
Mar/Apr 2019 Pg. 163-166	Evaluation of the Physicochemical Stability of Amiodarone Hydrochloride in Syringes for the Intensive Care Unit Author(s): Lardinois Benjamin, Dimitriou Alexandre, Delcave Charlotte, Jamart Jacques, Bihin Benoît, Soumoy Laura, Hecq Jean-Daniel, Galanti Laurence M
Mar/Apr 2019 Pg. 167-175	Physicochemical Stability of Extemporaneously Prepared Methylcobalamin Injections in the Presence and Absence of Preservative and the Impact of Light Exposure Author(s): Ip Kendice, Banov Daniel, Bassani Gus, Morgan Latisha
May/Jun 2019 Pg. 180	PreScription: Honesty/Ethics in Professions: The Gallup Polls Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 182-186	How to Develop and Maintain a Hazardous Drug List Author(s): Dillon L Rad
May/Jun 2019 Pg. 188-191	Summary of Educational Offerings Provided by Compounding Support Companies in 2019 Author(s): Stevens J Tyler
May/Jun 2019 Pg. 192-199	Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome) Author(s): Riepl Mike
May/Jun 2019 Pg. 200-207	Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 1 Author(s): Zur Eyal
May/Jun 2019 Pg. 208-209	Can We Fix It? Author(s): Brunner Scott
May/Jun 2019 Pg. 211-216	Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 1: Physical and Chemical Testing Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 221-228	Basics of Sterile Compounding: Vehicles Used in Sterile Compounding Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 229	Calculations Author(s): Stockton Shelly J
May/Jun 2019 Pg. 230	Aripiprazole 1 mg/mL in Methylcellulose 1% Syrup Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 231	Chloroquine Phosphate 15 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 232	Clopidogrel 5 mg/mL in a Sugar-Free Syrup Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 233	Flunisolide Nasal Spray Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 234	Mebeverine Hydrochloride 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 235	Methotrexate 2-mg/mL Oral Solution Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 236	Sildenafil 2.5 mg/mL in Ora-Plus:Ora-Sweet Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 237	Valsartan 16-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 238-244	Evaluation of the Quality of Sterile Compounding Videos Available on the YouTube Video-sharing Website Author(s): Sluggett Janet K, Johnson Michelle J, Zamani Mazdak, Kastango Eric S, Bodnar Mark, Cantor Peter, Hobbs Jodie G, Reynolds Karen J, Sluggett Andrew J
May/Jun 2019 Pg. 245-249	Trends of Extemporaneous Drug Prescription in Latvia in 2017 Author(s): Kiselova Olga, Maurina Baiba, Sidlovska Venta, Rogovska Irena
May/Jun 2019 Pg. 250-257	Compounding and Comparative Study of a Superior, Faster, and More Adaptable Lidocaine Dental Gel Formulation Author(s): Rashid Mamoon, Hossain Mohammad Faisal, Nounou Mohamed, Rahman Mehbuba, Sarkar Sushanta, Adeyemo Akinola, Mullins Randy
May/Jun 2019 Pg. 258-263	An Exploratory Study of Suboxone (Buprenorphine/Naloxone) Film Splitting: Cutting Methods, Content Uniformity, and Stability Author(s): Reindel Kristin L, DeAngelis Michael J, Ferrara Alexander S, Conn Kelly M, Phillips Elizabeth M, Corigliano Anthony T, Zhao Fang
Jul/Aug 2019 Pg. 268	PreScription: Temperatures by Degrees Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 271-278	Contamination Control in Compounding Areas Author(s): Mulder Kyle, Gonzales Ben A
Jul/Aug 2019 Pg. 281-287	Mean Kinetic Temperature for Controlled Room Temperature Drug Storage: Official Definitions and Example Calculations Author(s): Newton David W
Jul/Aug 2019 Pg. 288-293	Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 2 Author(s): Zur Eyal
Jul/Aug 2019 Pg. 294-296	Now Is the Time for All Good Compounders to Come to the Aid of Their Profession: What You Do Right Now to Advance Compounding's Advocacy Priorities Can Help Assure Your Profession's Future Author(s): Brunner Scott
Jul/Aug 2019 Pg. 299-303	Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 2: Microbiological Testing Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 305-311	Basics: Excipients Used in Nonsterile Compounding, Part 1 Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 312-313	Calculations Author(s): Stockton Shelly J, Drinnon Stephen D
Jul/Aug 2019 Pg. 314	Aripiprazole 1 mg/mL in Oral-Plus:Ora-Sweet (1:1) Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 315	Candesartan Cilexetil 1 mg/mL in Syrup NF or Vehicle for Oral Solution USP Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 316	Domperidone 5 mg/mL in Oral Mix Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 317	Lorazepam 1 mg/mL in Anhydrous Organic Solvent System Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 318	Morphine Sulfate 0.2-mg/mL Solution Stored in Amber Oral Plastic Syringes Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 319	Rifampin 25 mg/mL in SyrSpend SF Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 320-323	Long-term Physicochemical Stability of Concentrated Solutions of Sodium Valproate in Polypropylene Syringes for Administration in the Intensive Care Unit Author(s): Lardinois Benjamin, Baltzis Alexandre, Braibant Maximilien, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence
Jul/Aug 2019 Pg. 324-331	Extemporaneous Indomethacin Oral Suspension Prepared from Injectable Ampules for Therapy in Premature Infants and Pediatric Patients Author(s): de Lafuente Yanina, García Mónica Cristina, Jiminez-Kairuz Alvaro
Jul/Aug 2019 Pg. 325-339	Subcutaneous Testosterone Anastrozole Therapy in Men: Rationale, Dosing, and Levels on Therapy Author(s): Glaser Rebecca L, York Anne E
Jul/Aug 2019 Pg. 340-350	Development and Validation of a Stability-indicating High-performance Liquid Chromatographic Method for Quantification of Progesterone in Compounded Glycerinated Gelatin Troches Author(s): Burrows Anna C, Yellepeddi Venkata Kashyap, Snyder Spencer, Wakefield Meagan, Jackson David, Huynh Johnny, Nguyen Khoa, Sayre Casey L
Jul/Aug 2019 Pg. 351	Erratum: Zur E. Topical Treatment of Primary Focal Hyperhidrosis, Part 2. IJPC 2019; 23(2):94-104. Author(s):
Jul/Aug 2019 Pg. 351	Erratum: Kiselova O, Maurina B, Sidlovska V et al. Trends of Extemporaneous Drug Prescription in Latvia in 2017. IJPC 2019; 23(3): 245-249. Author(s):
Sep/Oct 2019 Pg. 356	PreScription: Regulations, Laws, Standards, Guidelines, Procedures, Etc Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 358-364	Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report Author(s): Pope George, Daleo Charles, Batson SL
Sep/Oct 2019 Pg. 366-375	Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 3 Author(s): Zur Eyal
Sep/Oct 2019 Pg. 376-381	Oral Viscous Sucralfate Gel for Post-procedural Treatment of Barrett's Esophagus Author(s): Zur Eyal
Sep/Oct 2019 Pg. 383-385	Threading the Needle Author(s): Brunner Scott
Sep/Oct 2019 Pg. 387-391	Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 1 Author(s): Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
Sep/Oct 2019 Pg. 393-396	Basics: Excipients Used in Nonsterile Compounding, Part 2 Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 399-402	Sterile Basics: Pharmaceutical Waters Used in Sterile and Nonsterile Compounding Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 404	Calculations Author(s): Stockton Shelly J
Sep/Oct 2019 Pg. 406	Allopurinol 20 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 407	Amitriptyline Hydrochloride 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 408	Dipyridamole 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 409	Omeprazole 2 mg/mL in SyrSpend SF Alka (Reconstituted) Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 410	Oxandrolone 3 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 411	Sorafenib Capsules for Pediatric Use Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 412	Valsartan 4 mg/mL in Vehicle for Oral Solution USP Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 413	Verapamil Hydrochloride 50 mg/mL in Ora-Plus:Ora-Sweet (1:1) Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 414-417	Stability of Furosemide 5 mg/mL in Polypropylene Syringes Author(s): van der Schaar JAJ, Grouls R, Franssen EJF, Crul M
Sep/Oct 2019 Pg. 418-421	Measurement of Free Iodine in Different Formulations of Povidone-Iodine Eye Drops 5% Author(s): Berisa Prado Silvia, Riestra Ayora Ana Cristina, Trelles Campa Adrián
Sep/Oct 2019 Pg. 422-427	The Current Landscape of Veterinary Compounding in the Pharmacy Setting Author(s): Gochenauer Alexandria E, Holmes Erin R, Barber Katie E, Forsythe Lauren R
Sep/Oct 2019 Pg. 428-433	The Current Landscape of Veterinary Compounding in the Veterinary Setting Author(s): Gochenauer Alexandria E, Rishniw Mark, Holmes Erin R, Forsythe Lauren R
Sep/Oct 2019 Pg. 434-437	Long-term Physiochemical Stability of Concentrated Solutions of Salbutamol (Albuterol) in Polypropylene Syringes for Use in the Intensive Care Unit and in Obstetrics Author(s): Lardinois Benjamin, Baltzis Alexandre, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence
Sep/Oct 2019 Pg. 438	Erratum: McNulty JP, Hahn K. Compounded oral ketamine for severe depression, anxiety, and pain in a hospice patient with end-stage chronic obstructive pulmonary disease, cardiopulmonary failure, and severe : A case report. IJPC. 2012; 16(5): 364–368. Author(s):
Sep/Oct 2019 Pg. 438	Erratum: Stevens JT. Summary of educational offerings provided by compounding support companies in 2019. IJPC. 2019; 23(3): 188–191. Author(s):
Nov/Dec 2019 Pg. 444	PreScription: As Things Change…. Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 447-452	Primary Engineering Controls in Pharmaceutical Compounding, Part 1: Unidirectional-airflow Workstations, Compounding Aseptic Isolators, and Compounding Aseptic Containment Isolators Author(s): Mulder Kyle
Nov/Dec 2019 Pg. 454-461	How to Qualify Container Closure Systems for Intended Use, Part 1 Author(s): Kim Amy A, Gehrmann Matthew R, McCaw James, McAndrew T Page
Nov/Dec 2019 Pg. 462-464	Are You Part of the Solution or Part of the Problem? Author(s): Brunner Scott
Nov/Dec 2019 Pg. 467-471	Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 2 Author(s): Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
Nov/Dec 2019 Pg. 472-477	Basics: Excipients Used in Nonsterile Compounding, Part 3: Preservatives Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 478-482	Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 484	Calculations Author(s): Stockton Shelly J, Stover Emily M
Nov/Dec 2019 Pg. 486	Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 487	Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 488	Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 489	Riboflavin 10 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 490	Sulfasalazine 100 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 491	Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 492	Tadalafil 5 mg/mL in Oral-Plus:Ora-Sweet (1:1) Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 493	Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 494	Verapmail Hydrochloride 50 mg/mL in SyrSpend SF Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 495	Zonisamide 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 496-503	Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy? Author(s): Shakshuki Ayah, Agu Remigius U
Nov/Dec 2019 Pg. 504-510	Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid Author(s): Chuong Monica, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G
Nov/Dec 2019 Pg. 511-518	Evaluation of Containment Ventilated Enclosure Performance in Absence of Negative Pressure Containment Secondary Engineering Control Author(s): Hutson Chad, Day A J
Nov/Dec 2019 Pg. 519-527	Physicochemical Stability of Compounded Amlodipine Besylate Suspensions in PCCA Base, SuspendIt Author(s): Graves Richard A, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Swopes Demikka, Morris Tommy C, Pramar Yashoda V